TrialJournal of Crohn's & colitis2021

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.

Séverine Vermeire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.